Friday, October 23, 2015

The "new" 23andMe

23andMe has now received FDA approval to resume marketing of its autosomal test for health purposes. It appears its ancestry testing will not change, meaning it will continue to be an alternative to and to Family Finder by Family Tree DNA but now at double the price of those two.

The resumption of health reports is welcome news. You can read more at and at

No comments: